紫杉醇类似物抗癌活性与分子结构的定量构效关系

来源 :中草药 | 被引量 : 0次 | 上传用户:zhanglq
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的为了寻找新一代紫杉醇类抗癌药物,研究紫杉醇类似物分子结构和抗癌活性(PIDact)之间的定量构效关系。方法基于电性状态拓扑指数和电性距离矢量,应用最佳子集回归的方法建立了PIDact值和紫杉醇类似物分子结构的定量结构–活性相关(QSAR)模型,并对模型进行了交互检验和外部检验,用43个紫杉醇类似物训练集样本构建的QSAR模型预测了外部10个检验集的PIDact值。结果所建立模型具有较高的估计相关系数及LOO(leave-one-out)检验相关系数。结论模型具有良好估计能力与稳定性,训练集模型具有良好预测能力。 In order to find a new generation of paclitaxel anti-cancer drugs, the quantitative structure-activity relationship between the molecular structure of paclitaxel analogs and the anti-cancer activity (PIDact) was studied. Methods Quantitative structure-activity correlation (QSAR) models of PIDact value and paclitaxel analogue molecular structure were established by the best subset regression method based on the electrical state topological index and electrical distance vector. The model was interactively tested and Externally, the QSAR model constructed with 43 paclitaxel analog training samples predicts PIDact values ​​for the 10 external test sets. Results The model established had higher estimated correlation coefficient and LOO (leave-one-out) test correlation coefficient. Conclusion The model has a good estimation ability and stability, and the training set model has good predictive ability.
其他文献
公共场所的卫生状况关系到人民群众的身体健康,是公共卫生监督管理的重点领域。近年来,随着法律法规的逐步完善和执法监督力度的加大,公共场所的卫生状况有了明显改观,但在实
目的:探讨注射用双黄连(SHLI)发生类过敏反应的物质基础及其作用机制。方法:①类过敏反应和致类过敏物质研究:ICR小鼠随机分成不同实验组,分别一次性静脉注射含有0.4%伊文思